Mount Sinai Discovers New Drug Combo to Induce High Rates of Human Beta Cell Regeneration

Researchers at the Icahn School of Medicine at Mount Sinai have discovered a novel combination of two classes of drugs that, together, cause the highest rate of proliferation ever observed in adult human beta cells—the cells in the pancreas that produce insulin—without harming most other cells in the body. The result is an important step toward a diabetes treatment that restores the body’s ability to produce insulin.

Read more

Mount Sinai St. Luke’s Renamed Mount Sinai Morningside

New name clarifies the key role the hospital plays in the Mount Sinai Health System, honors the community the hospital serves, and reflects the considerable investments that have brought technologically advanced Mount Sinai-level care to the residents of Upper Manhattan, Westchester, New Jersey, and beyond.

Read more

Global Team Enables Child With a Fatal Genetic Disease to Recover

A young boy with a rare genetic disease that typically kills within weeks of birth is now 3 years old and in remission thanks to a collaborative effort that included physicians at King Saud University Department of Pediatrics and immunologists at the Icahn School of Medicine at Mount Sinai.

Read more